• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大疱性固定性药物疹:一个潜在的诊断陷阱:18 例研究。

Bullous fixed drug eruption: A potential diagnostic pitfall: a study of 18 cases.

机构信息

Dermatology Department, Habib Thameur Hospital, 1089 Tunis, Tunisia.

National Center of Pharmacovigilance, 1002 Tunis, Tunisia.

出版信息

Therapie. 2019 Oct;74(5):527-530. doi: 10.1016/j.therap.2019.01.009. Epub 2019 Mar 31.

DOI:10.1016/j.therap.2019.01.009
PMID:31006486
Abstract

BACKGROUND

Bullous fixed drug eruption (BFDE) is a rare and particular adverse drug reaction characterized by localized or generalized blisters and erosions, which can be confused with Stevens-Johnson syndrome, toxic epidermal necrolysis, major erythema multiforme and autoimmune bullous dermatosis.

OBJECTIVE

The aim of our study was to assess the epidemiological, clinical and therapeutic features and outcome of BFDE.

METHODS

A retrospective and descriptive study collecting all observations of BFDE was conducted in the dermatology department of Habib Thameur Hospital in Tunisia, over an 18-year period (2000-2017). The diagnosis of BFDE was confirmed by histopathological examination and all the patients underwent pharmacovigilance investigation.

RESULTS

Totally, 18 cases were enrolled in our study with BFDE. The mean age was 57.9 years with a sex ratio M/F of 1. BFDE was localized in 8 cases and generalized in 10 cases. It was the first episode of BFDE in 11 patients and a recurrence in 7 patients. Drugs involved in the genesis of BFDE in our study were mainly non-steroidal anti-inflammatory drugs in 10 patients and antibiotics in 5 cases. Drug patch tests were performed in four patients on the residual plaques of FDE (fixed drug eruption) and were positive to the suspected drug. A favorable outcome was observed in all our patients under treatment and after suspected drug withdrawal.

CONCLUSION

BFDE is a rare adverse drug reaction and could be severe especially when it presents as a generalized eruption. Drugs involved are mainly non-steroidal anti-inflammatory drugs followed by antibiotics.

摘要

背景

大疱性固定性药物疹(BFDE)是一种罕见且特殊的药物不良反应,其特征为局部或全身性水疱和糜烂,易与史蒂文斯-约翰逊综合征、中毒性表皮坏死松解症、大疱性多形红斑和自身免疫性大疱性皮肤病相混淆。

目的

本研究旨在评估 BFDE 的流行病学、临床和治疗特征及结局。

方法

在突尼斯哈比卜·图迈尔医院皮肤科进行了一项回顾性描述性研究,收集了 18 年来(2000-2017 年)所有 BFDE 观察病例。通过组织病理学检查确诊 BFDE,所有患者均进行了药物警戒调查。

结果

本研究共纳入 18 例 BFDE 患者。平均年龄为 57.9 岁,男女比例为 1:1。BFDE 局部性 8 例,全身性 10 例。11 例为首次发病,7 例为复发。本研究中导致 BFDE 的药物主要为非甾体类抗炎药 10 例,抗生素 5 例。对 FDE(固定性药物疹)残留斑块进行 4 例药物斑贴试验,均对可疑药物呈阳性。所有患者经治疗和可疑药物停用后均获得良好结局。

结论

BFDE 是一种罕见的药物不良反应,尤其是全身性发作时可能较为严重。涉及的药物主要是非甾体类抗炎药,其次是抗生素。

相似文献

1
Bullous fixed drug eruption: A potential diagnostic pitfall: a study of 18 cases.大疱性固定性药物疹:一个潜在的诊断陷阱:18 例研究。
Therapie. 2019 Oct;74(5):527-530. doi: 10.1016/j.therap.2019.01.009. Epub 2019 Mar 31.
2
Clinical and histological features of fixed drug eruption: a single-centre series of 73 cases with comparison between bullous and non-bullous forms.固定性药物疹的临床和组织学特征:单中心 73 例的系列研究,比较水疱性和非水疱性形式。
Eur J Dermatol. 2021 Jun 1;31(3):372-380. doi: 10.1684/ejd.2021.4051.
3
Generalized bullous fixed drug eruption is distinct from Stevens-Johnson syndrome/toxic epidermal necrolysis by immunohistopathological features.泛发性大疱性固定型药物疹与史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症的免疫组织病理学特征不同。
J Am Acad Dermatol. 2014 Mar;70(3):539-48. doi: 10.1016/j.jaad.2013.11.015. Epub 2014 Jan 2.
4
Bullous fixed drug eruption masquerading as recurrent Stevens Johnson syndrome.伪装成复发性史蒂文斯-约翰逊综合征的大疱性固定性药疹。
J Emerg Med. 2015 May;48(5):551-4. doi: 10.1016/j.jemermed.2014.09.049. Epub 2014 Nov 27.
5
Clinical resemblance of widespread bullous fixed drug eruption to Stevens-Johnson syndrome or toxic epidermal necrolysis: report of two cases.广泛大疱性固定性药疹与史蒂文斯-约翰逊综合征或中毒性表皮坏死松解症的临床相似性:两例报告
J Formos Med Assoc. 2002 Aug;101(8):572-6.
6
Generalized bullous fixed drug eruption imitating toxic epidermal necrolysis: a case report and literature review.酷似中毒性表皮坏死松解症的泛发性大疱性固定型药疹:1例报告及文献复习
Dermatol Online J. 2017 Jul 15;23(7):13030/qt25v009gs.
7
[Unintended rechallenge : Generalized bullous fixed drug eruption in two elderly women].[意外再激发:两名老年女性发生的全身性大疱性固定性药疹]
Hautarzt. 2017 Jan;68(1):59-63. doi: 10.1007/s00105-016-3850-y.
8
Drug-induced linear IgA bullous dermatosis mimicking toxic epidermal necrolysis.药物性线性IgA大疱性皮肤病酷似中毒性表皮坏死松解症。
Dermatology. 2001;202(2):138-9. doi: 10.1159/000051615.
9
Bullous Drug Reactions.大疱性药物不良反应。
Acta Derm Venereol. 2020 Feb 12;100(5):adv00057. doi: 10.2340/00015555-3408.
10
Ibuprofen-induced bullous leukocytoclastic vasculitis.布洛芬诱发的大疱性白细胞破碎性血管炎。
Cutis. 2001 Apr;67(4):303-7.

引用本文的文献

1
Generalized Bullous Fixed Drug Eruption Induced by Chlordiazepoxide: A Case Report of a Potentially Lethal Adverse Effect.氯氮卓引起的泛发性大疱性固定性药疹:一例潜在致命不良反应的病例报告
Consort Psychiatr. 2025 Mar 7;6(1):30-36. doi: 10.17816/CP15563. eCollection 2025.
2
Angina Bullosa Hemorrhagica - A Case Series.出血性大疱性心绞痛——病例系列
Indian J Dermatol. 2023 Sep-Oct;68(5):563-568. doi: 10.4103/ijd.ijd_663_21.
3
Case report: Generalized bullous fixed drug eruption mimicking epidermal necrolysis.病例报告:酷似中毒性表皮坏死松解症的泛发性大疱性固定性药疹。
Front Med (Lausanne). 2023 Aug 14;10:1125754. doi: 10.3389/fmed.2023.1125754. eCollection 2023.
4
The Role of Sex and Gender in Dermatology - From Pathogenesis to Clinical Implications.性与性别在皮肤病学中的作用——从发病机制到临床意义。
J Cutan Med Surg. 2023 Jul-Aug;27(4):NP1-NP36. doi: 10.1177/12034754231177582. Epub 2023 Jul 4.
5
Hypopigmented penile fixed drug eruption.阴茎部色素减退性固定性药疹。
Clin Case Rep. 2022 Sep 24;10(9):e6364. doi: 10.1002/ccr3.6364. eCollection 2022 Sep.
6
A Review of Fixed Drug Eruption with a Special Focus on Generalized Bullous Fixed Drug Eruption.固定型药物疹的综述,重点关注全身性大疱性固定型药物疹。
Medicina (Kaunas). 2021 Sep 1;57(9):925. doi: 10.3390/medicina57090925.
7
Loss of tolerance 5 days after discontinuing sulphonamide introduced via desensitization in delayed reaction.在通过脱敏引入磺胺类药物后5天,迟发性反应中出现耐受性丧失。
Einstein (Sao Paulo). 2019 Nov 25;18:eRC5002. doi: 10.31744/einstein_journal/2020RC5002. eCollection 2020.